U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 076000

Expand all

OLANZAPINE (OLANZAPINE)
2.5MG
Marketing Status: Discontinued
Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076000
Product Number: 001
Approval Date: Oct 24, 2011
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:  Discontinued
Patent and Exclusivity Information
OLANZAPINE (OLANZAPINE)
5MG
Marketing Status: Discontinued
Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076000
Product Number: 002
Approval Date: Oct 24, 2011
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:  Discontinued
Patent and Exclusivity Information
OLANZAPINE (OLANZAPINE)
7.5MG
Marketing Status: Discontinued
Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076000
Product Number: 003
Approval Date: Oct 24, 2011
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:  Discontinued
Patent and Exclusivity Information
OLANZAPINE (OLANZAPINE)
10MG
Marketing Status: Discontinued
Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076000
Product Number: 004
Approval Date: Oct 24, 2011
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:  Discontinued
Patent and Exclusivity Information
OLANZAPINE (OLANZAPINE)
15MG
Marketing Status: Discontinued
Active Ingredient: OLANZAPINE
Proprietary Name: OLANZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A076000
Product Number: 005
Approval Date: Oct 24, 2011
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top